Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

Cutaneous Lupus Clinical Trial

Official title:
A Comparative Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

Status Terminated

Clinical Trial Summary

This study aims to compare the efficacy of 532nm Potassium Titanyl Phosphate (KTP) laser and 1064 nm Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) laser as adjuncts to topical corticosteroids in the treatment of cutaneous lupus erythematosus versus topical corticosteroids alone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cutaneous Lupus

Clinical Trial Details

NCT number	NCT03639857
Study type	Interventional
Source	University of Central Florida
Contact
Status	Terminated
Phase	N/A
Start date	August 17, 2018
Completion date	December 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05048238` - Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus	Phase 1
Terminated	`NCT01389895` - Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus	Phase 1
Completed	`NCT03122431` - Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases	Phase 4
Recruiting	`NCT00512694` - Duke Lupus Registry
Completed	`NCT01408199` - Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus	Phase 4
Recruiting	`NCT03276923` - Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Active, not recruiting	`NCT02176148` - Cutaneous Lupus Medication Experience Study
Completed	`NCT03288324` - Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus	Phase 1/Phase 2
Terminated	`NCT01164917` - Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus	Phase 1
Completed	`NCT00513591` - Duke Autoimmunity in Pregnancy Registry